Quarterly report pursuant to Section 13 or 15(d)

SEGMENTS (Details)

v3.21.2
SEGMENTS (Details)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2020
USD ($)
Facility
Mar. 31, 2020
USD ($)
Jun. 30, 2021
USD ($)
Facility
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Segment Reporting Information [Abstract]              
Number of FDA-licensed plasma collection facilities | Facility     2   2    
Number of plasma collection facilities under development | Facility     8   8    
Revenues $ 17,830,590   $ 7,787,594   $ 33,879,208 $ 17,987,338  
Cost of product revenue 18,832,624   13,495,629   36,602,746 30,324,855  
Loss from operations (15,581,232)   (17,123,825)   (30,745,481) (33,893,611)  
Interest and other expense, net (3,324,071)   (3,054,266)   (6,539,763) (5,529,710)  
Net loss (18,905,303) $ (18,379,941) (20,178,091) $ (19,245,230) (37,285,244) (39,423,321)  
Capital expenditures         7,046,735 6,243,284  
Depreciation and amortization expense 1,325,994   885,652   2,555,622 1,674,490  
Total assets 232,813,792   191,541,568   232,813,792 191,541,568 $ 207,673,394
United States [Member]              
Segment Reporting Information [Abstract]              
Revenues 15,424,839   6,797,170   29,102,848 15,453,443  
International [Member]              
Segment Reporting Information [Abstract]              
Revenues 2,405,751   990,424   4,776,360 2,533,895  
Corporate [Member]              
Segment Reporting Information [Abstract]              
Revenues 35,709   35,709   71,417 71,417  
Cost of product revenue 0   0   0 0  
Loss from operations (4,449,608)   (3,351,681)   (8,137,328) (7,188,167)  
Interest and other expense, net (3,244,912)   (2,818,791)   (6,438,706) (5,055,363)  
Net loss (7,694,520)   (6,170,472)   (14,576,034) (12,243,530)  
Capital expenditures         0 0  
Depreciation and amortization expense 1,530   2,305   3,397 4,881  
Total assets 42,420,872   74,893,664   42,420,872 74,893,664  
Operating Segments [Member] | ADMA BioManufacturing [Member]              
Segment Reporting Information [Abstract]              
Revenues 16,347,880   6,502,865   29,768,923 14,246,139  
Cost of product revenue 17,382,292   12,237,141   32,832,049 26,689,094  
Loss from operations (8,337,405)   (12,852,835)   (17,843,093) (25,328,980)  
Interest and other expense, net (78,793)   (235,442)   (100,307) (474,314)  
Net loss (8,416,198)   (13,088,277)   (17,943,400) (25,803,294)  
Capital expenditures         2,725,432 5,064,494  
Depreciation and amortization expense 1,055,537   772,241   2,065,307 1,447,214  
Total assets 169,799,509   109,105,418   169,799,509 109,105,418  
Operating Segments [Member] | Plasma Collection Centers [Member]              
Segment Reporting Information [Abstract]              
Revenues 1,447,001   1,249,020   4,038,868 3,669,782  
Cost of product revenue 1,450,332   1,258,488   3,770,697 3,635,761  
Loss from operations (2,794,219)   (919,309)   (4,765,060) (1,376,464)  
Interest and other expense, net (366)   (33)   (750) (33)  
Net loss (2,794,585)   (919,342)   (4,765,810) (1,376,497)  
Capital expenditures         4,321,303 1,178,790  
Depreciation and amortization expense 268,927   111,106   486,918 222,395  
Total assets $ 20,593,411   $ 7,542,486   $ 20,593,411 $ 7,542,486